Mendel Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 143

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $40M

  • Investors
  • 13

Mendel General Information

Description

Developer of healthcare software designed to solve problems at each stage of the clinical trial process. The company's software combines machine precision and human intuition from feasibility to post-trial pharmacovigilance as well as transforms unstructured EMR data and clinical literature into comprehensive and compliant analytics-ready data, enabling clinical experts to streamline global oncology research by automating clinical trials.

Contact Information

Website
www.mendel.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 111 West Saint John Street
  • Suite 950
  • San Jose, CA 95113
  • United States
+1 (877) 000-0000

Mendel Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mendel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 25-Mar-2022 $40M 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series A) 29-Nov-2021 000.00 000.00 0000 Completed Generating Revenue
4. Later Stage VC (Series A) 07-Jun-2021 0000 0000 0000 Completed Generating Revenue
3. Seed Round 11-Jul-2017 000 000 000 Completed Generating Revenue
2. Accelerator/Incubator 18-Aug-2016 $250K $4M Completed Startup
1. Angel (individual) 01-Jan-2016 $3.75M $3.75M Completed Startup
To view Mendel’s complete valuation and funding history, request access »

Mendel Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A 16,565,358 $0.000010 $0.05 $0.9 $0.9 1x $0.9 14.51%
Seed 6,598,224 $0.000010 $0.02 $0.36 $0.36 1x $0.36 5.78%
To view Mendel’s complete cap table history, request access »

Mendel Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of healthcare software designed to solve problems at each stage of the clinical trial process. The company's s
Enterprise Systems (Healthcare)
San Jose, CA
143 As of 2024
000.00
00000 0000-00-00
00000000000 000.00

000000

e et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ull
00000 0000000000 000
Minnetonka, MN
00 As of 0000
000.00
000.00 0000-00-00
00000000000 000.00

000000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
00000 0000000000 000
Malvern, PA
000 As of 0000
000.00
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mendel Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MedNet (Other Healthcare Technology Systems) Venture Capital-Backed Minnetonka, MN 00 000.00 00000000000 000.00
YPrime Private Equity-Backed Malvern, PA 000 000.00 000000000 -
OpenClinica Private Equity-Backed Needham, MA 00 0000000 0000
Medrio Venture Capital-Backed San Francisco, CA 000 000.00 00000 00000 000.00
CloudMedx Venture Capital-Backed Palo Alto, CA 00 000.00 000000000000 000.00
You’re viewing 5 of 24 competitors. Get the full list »

Mendel Executive Team (11)

Name Title Board Seat Contact Info
Karim Galil MD Co-Founder, Chief Executive Officer, Chairman
Wael Salloum Ph.D Co-Founder, Chief Science Officer & Board Member
Sean Greenleaf Executive of GTM Strategy
Kevin Kooi Senior Vice President of Finance & Operations
Jon Boersma Senior Vice President of GTM
You’re viewing 5 of 11 executive team members. Get the full list »

Mendel Board Members (8)

Name Representing Role Since
Brian Longo Self Board Member 000 0000
Nichola Eliovits Olive Tree Capital Board Observer 000 0000
Nicolai Wadstrom BootstrapLabs Board Member 000 0000
Wael Salloum Ph.D Mendel Co-Founder, Chief Science Officer & Board Member 000 0000
William Deitch Oak HC/FT Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Mendel Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mendel Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Oak HC/FT Venture Capital Minority 000 0000 000000 0
Hi Ventures Venture Capital Minority 000 0000 000000 0
Millennium Technology Value Partners Venture Capital Minority 000 0000 000000 0
Olive Tree Capital Venture Capital Minority 000 0000 000000 0
Advisors.Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Mendel FAQs

  • When was Mendel founded?

    Mendel was founded in 2016.

  • Who is the founder of Mendel?

    Karim Galil MD, Ruchi Deshpande Ph.D, and Wael Salloum Ph.D are the founders of Mendel.

  • Who is the CEO of Mendel?

    Karim Galil MD is the CEO of Mendel.

  • Where is Mendel headquartered?

    Mendel is headquartered in San Jose, CA.

  • What is the size of Mendel?

    Mendel has 143 total employees.

  • What industry is Mendel in?

    Mendel’s primary industry is Enterprise Systems (Healthcare).

  • Is Mendel a private or public company?

    Mendel is a Private company.

  • What is the current valuation of Mendel?

    The current valuation of Mendel is 00000.

  • What is Mendel’s current revenue?

    The current revenue for Mendel is 00000.

  • How much funding has Mendel raised over time?

    Mendel has raised $78.9M.

  • Who are Mendel’s investors?

    Oak HC/FT, Hi Ventures, Millennium Technology Value Partners, Olive Tree Capital, and Advisors.Fund are 5 of 13 investors who have invested in Mendel.

  • Who are Mendel’s competitors?

    MedNet (Other Healthcare Technology Systems), YPrime, OpenClinica, Medrio, and CloudMedx are some of the 24 competitors of Mendel.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »